XLO · Xilio Therapeutics, Inc.
Market Cap
$52.10M
Shares
5.78M
Volume · Oct 9
272
Avg daily vol (3M)
19.08K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.01
Open$9.01
Day$8.78–9.14
52W close$7.14–11.90
Avg vol 30d10K
Short int413K · 7.1% float · 37.4d
Short vol32%
Last earningsNov 13, 2025
DataOct 2021–Oct 2026
Filing10-Q · Aug 12
Up next
filed Aug 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$64.09M
Trailing 12 months
Net income (TTM)
−$21.83M
Trailing 12 months
Revenue growth YoY
+131.2%
Year over year
Operating margin
-48.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-117.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$136.04M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+38.6%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
7.1%
Latest settlement · 37.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+5%
above
Price vs 50-day avg
−1%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
39%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+5%
trailing
YTD return
+1%
this year
Relative strength
−4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $9 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
7.14% of float · ▼ -1.3% MoM · 37.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — mid 3-yr range
Squeeze score
75
high risk · 0–100
Fundamentals
Revenue growth
+590%
Y/Y
EPS growth
+73%
Y/Y
Free cash flow
$-5.5M
Quant / Vol
risk profile
Volatility
44%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+5%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
39%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $9 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
7.14% of float · ▼ -1.3% MoM · 37.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $7
Now $9 · 39%
Range high $12
vs 200-day avg +5%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XLO
this stock
Xilio Therapeutics, Inc.
|
$52.10M | — | +589.9% | — | 7.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$127.55B | +11.0% | +46.2% | 29.3 | 1.9% |
|
MRNA
Moderna, Inc.
|
$78.65B | +568.0% | +4.3% | — | 8.2% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$76.14B | -4.2% | +20.8% | 18.3 | 2.5% |
|
CSLLY
Csl Ltd
|
$60.24B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XLO | +1.1% | +0.9% | +5.1% | -0.4% | +0.6% |
| SPY | +1.3% | +2.1% | +9.0% | +1.5% | +13.5% |
| vs SPY | -0.2% | -1.2% | -3.9% | -1.9% | -12.9% |